The Bulletin
The Times


.

Actinogen announces peer-reviewed clinical pharmacology manuscript for Xanamem (emestedastat) published in Clinical Pharmacology in Drug Development journal

  • Written by PR Newswire
Actinogen announces peer-reviewed clinical pharmacology manuscript for Xanamem (emestedastat) published in Clinical Pharmacology in Drug Development journal

Confirms the utility of the 10 mg daily oral dose of Xanamem being studied in late-stage clinical trials in Alzheimer's disease and major depressive disorder 

SYDNEY, Feb. 12, 2025 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) announces that the publication of its most recent peer-reviewed journal article entitled Clinical Pharmacology...

The Bulletin Magazine

Mesh Rack Solutions for Practical Warehouse Storage

Cardboard Box Manufacturers and the Packaging Selection Process

What Happens After Someone Dies? Understanding the Probate Process

How to Choose a Sliding Screen Door for Indoor-Outdoor Living

What the Label on a Pallet Tells a Warehouse Before Anyone Opens It

Executive Recruitment for Education Leadership: What Schools Should Consider

Practical Guide to Roller Shutters for Safer, More Comfortable Homes

Why the Advertised Rate on a Bonus Saver Account Isn't What Most Savers Actually Earn

The Essential Bathroom Renovation Supplies Checklist Before You Start

Pull Up Stands: A Convenient Display Option for Events and Promotions

How Mining Hose Selection Can Improve Material Transfer Systems

Electric Sliding Door: What to Consider Before Choosing One

hacklink esim balkanzlibraryzlibraryz-libraryFanatikbettaraftariumjojobethacklink panelmarsbahisvsf watchesJojobet Girişuk casinos not on gamstopGamStopbahis casino siteleri